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 1. Introduction 
Gestational diabetes mellitus (GDM) affects 3% to 8% of pregnant women [1]. Women 
with a history of GDM fall into a young onset preliminary group for type 2 diabetes 
mellitus (DM). Women with a history of GDM should be followed-up for at least 6 to 
12 weeks after delivery to determine their glucose status. Between 2.6% and 38% of 
women with GDM developed DM within 12 weeks following delivery [2], [3], [4], [5]. 
The longest follow-up data suggested that up to 50% of women with a history of GDM 
may develop DM over a 20–30-year period [6] or that 30% will develop DM within 
10 years of childbirth [7]. The DM onset rate in women with GDM is approximately 7 
times higher than in those without GDM [8]. 
Evaluating postpartum glucose intolerance (GI) is important to prevent DM onset and 
the development of complications, as patients can then consider early interventions for 
glucose tolerance. However, risk factors for DM onset in women with a history of GDM 
remain to be elucidated. There have been several reports based on long-term 
observations of predictive factors for DM onset following GDM [9], [10]. 
The long-term follow-up rate of postpartum glucose testing is low in women with a 
history of GDM [11]. Annual follow-up rates after the first year postpartum are 
approximately 20% [12]. There are various barriers to postpartum diabetes testing, 
including lack of time to perform the glucose test, lack of knowledge that one may 
belong in a high-risk DM onset group, and lack of awareness among medical staff 
regarding the usefulness of the test [13], [14]. 
In this retrospective study, we aimed to clarify the predictive factors for the onset of 
impaired glucose tolerance (IGT) or DM diagnosed within a 2-year period following 
delivery among East Asian women after GDM, and to determine a cutoff glucose value 
for diagnosis of postpartum GI. Another aim of this study was to evaluate insulin 
secretion and insulin sensitivity for 2 years after women were diagnosed with GDM. 
Insulin secretion is commonly reduced in Asian populations [15]. When insulin 
secretion is lowered, women are likely to develop diabetes. Therefore, the association of 
examination results during pregnancy with insulin secretion 2 years later was tested. 
In our study, we focused not only on women who developed DM, but also on those who 
developed IGT. In contrast to impaired fasting glucose (IFG), IGT is a risk factor for 
cardiovascular disease among the Japanese population, and IGT is associated with a 
higher risk for developing type 2 DM than is IFG [16]. GDM is also a known risk factor 
for cardiovascular disease, and women with type 2 DM have a significant risk of 
developing cardiovascular disease [17], [18]. 
 2. Materials and methods 
 
2.1. Participants 
This retrospective, single-center, observational study reviewed data for women over a 2-
year period, following delivery at Chiba University hospital. During the study period, 
226 women who had been diagnosed with GDM, using the International Association of 
Diabetes and Pregnancy Study Groups (IADPSG) criteria [19], underwent a 75-g OGTT 
within 3 months postpartum at Chiba University hospital. A total of 226 women 
received an OGTT 3 months after delivery; however, after 2 years, 149 women did not 
undergo a 75-g OGTT for follow-up. After 3 months, 11 of the 226 women developed 
type 2 DM. After 1 year, 94 women returned for a glucose tolerance checkup using a 75-
g OGTT, and five women had newly-developed type 2 DM. After 2 years, 61 women 
underwent a 75-g OGTT; one woman had newly-developed type 2 DM, and 17 women 
were in an IGT state. We observed a total of 77 women with a history of GDM over a 2-
year period or longer, following delivery. Total number of women who diagnosed GDM 
was 273 women. Therefore the follow-up rate of OGTT was 82.7% after 3 months, 
34.4% after 1 year and 22.3% after 2 years respectively. 
Following childbirth, women are discharged from hospital after conducting a nutritional 
assessment. For mothers who breastfeed, the number of calories is set at 30 times the 
ideal body weight, and an extra 350 kcal is added. For mothers who do not breastfeed, 
the number of calories is set at 30 times the ideal body weight. For an obese mother 
(BMI > 25), the number of calories is set at 30 times the ideal body weight, even if they 
are breastfeeding. 
 
2.2. Glucose test and diagnosis 
All pregnant women at Chiba University hospital were screened for GDM between 10 
and 14 weeks gestation, and again between 24 and 28 weeks gestation. Pregnant women 
who satisfied the following conditions underwent a 75-g OGTT: (1) had casual blood 
glucose levels of 100 mg/dl or more at 10–14 weeks gestation; (2) had glucose levels of 
140 mg/dl or more at 60 min in a 50-g glucose challenge test at 24–28 weeks gestation; 
(3) were diagnosed with obesity (BMI of 27 kg/m2 or more); (4) had a family history of 
DM; (5) had a past history of macrosomia (more than 3500 g) or malformation; (6) were 
diagnosed with glycosuria; (7) received a diagnosis of large for gestational age fetus 
(estimated fetal body weight [EFBW] +2 standard deviations or more); (8) were 
diagnosed with polyhydramnios, and; (9) were older than 35 years of age. 
Using the IADPSG criteria, the patients were diagnosed as having GDM if one or more 
of the following were met: fasting blood glucose (FBG) levels of 92 mg/dl or more, 1-h 
glucose levels of 180 mg/dl or more, and 2-h glucose levels of 153 mg/dl or more with a 
75-g OGTT [19]. 
The main exclusion criteria included a previous diagnosis of type 1 and type 2 DM or 
being positive for type 1 DM autoimmune antibodies. In the present study, women who 
had overt DM during pregnancy were also excluded. The threshold values for a 
diagnosis of overt diabetes in pregnancy were defined as higher than 126 mg/dl in FBG 
and/or an HbA1c level of 6.5% (48 mmol/mol). 
 
2.3. Definitions 
Postpartum DM was defined as a 2-h glucose level higher than 200 mg/dl. (World 
Health Organization [WHO] criteria). IGT was defined as a fasting glucose level lower 
than 126 mg/dl, and a 120-min glucose level (Glu120) between 140 mg/dl and 
200 mg/dl. IFG was defined as a fasting glucose level between 110 mg/dl and 
126 mg/dl, and a Glu120 level lower than 140 mg/dl [20]. 
In addition, patients diagnosed using the Japan Diabetes Society diagnostic criteria, or 
who had started medication before a regular OGTT examination, were considered as 
DM onset patients [21]. 
One of the following criteria was used to define perinatal complications: amniotic fluid 
contaminated with meconium, a respiratory problem, an emergency cesarean section 
because of fetal growth restriction, shoulder dystocia, or pregnancy-induced 
hypertension. 
 
2.4. Statistical analysis 
We identified predictive factors for postpartum IGT or DM, expressed as GI in a 
diagnosis procedure. Clinical item predictive factors were analyzed using univariate 
logistic regression. The following parameters were assessed: age; level of glucose at 0, 
60, and 120 min in a 75-g OGTT during diagnosis; duration after GDM diagnosis; pre-
pregnancy BMI; family history of type 2 DM in first- and second-degree relatives; 
insulin therapy; diet therapy during pregnancy; total daily dose of insulin more than 20 
units; baby’s birth weight; duration of pregnancy; perinatal complication rate; and body 
weight gain during pregnancy. 
To determine the predictive factors for postpartum GI, five parameters (family history 
of type 2 DM in first degree relatives, levels of glucose at 60 min and at 120 min, 
HbA1c, and perinatal complications) with variables having P values <0.01 in univariate 
logistic regression were tested with multivariate logistic regression analyses, using the 
stepwise regression method. In our study, the most significant factors have been defined 
as variables with P values <0.05 in multivariate logistic regression analyses. 
Furthermore, we determined the cutoff values for each factor by receiver operating 
characteristic (ROC) analysis. Using these cutoff levels, we distinguished between two 
groups, and each group was analyzed for postpartum glucose state after 2 years. We 
compared the values using a 75-g OGTT, in particular, the glucose and insulin level, 
with the insulinogenic index as a parameter of insulin secretion and the Matsuda index 
as a parameter of insulin sensitivity. The differences between the two groups were 
analyzed using a Welch test on postpartum glucose tolerance. The study was approved 
by the Human Participants Committee of Chiba University School of Medicine, and 
informed consent was obtained. Statistical significance was determined for P values 
<0.05. All statistical analyses were performed using the JMP® 12 (SAS Institute Inc., 
Cary, NC, USA). 
 
3. Results 
 
3.1. Glucose intolerance after 2 years 
We enrolled 77 women (Table 1). By the end of the 2-year period, a final diagnosis was 
obtained. A total of 43 women had normal glucose tolerance (NGT), 17 were diagnosed 
with IGT, and 17 with DM. In total, 44.1% of women with a history of GDM had 
developed postpartum GI within 2 years. 
postpartum GI within 2 years. 
 
Table 1. Clinical characteristics of the patients. 
Number of patients 77 
Age at diagnosis (years) 34.33 ± 4.88 
Pre-pregnancy BMI (kg/m2) 23.91 ± 5.31 
Family history (%) 42.3/34.6 
Diagnosis time (weeks) 22.99 ± 7.88 
Treatment with insulin (%) 55.2 
Birth weight (g) (full-term only) 3086.27 ± 433.76 
Weeks of delivery 38.24 ± 2.13 
Perinatal complication (%) 24.8 
Values represent mean ± SD or percentage. 
Family history (%): representative of relatives with type 2 DM in first or second degree. 
BMI, body mass index; DM, diabetes mellitus; SD, standard deviation. 
There was no significant difference between the characteristics of women who were 
able to undergo OGTT for 2 years and women who dropped out on the way. 
 
3.2. Univariate and multivariate logistic regression analyses on postpartum glucose 
tolerance 
We identified specific predictive factors for postpartum GI using univariate logistic 
regression. According to univariate logistic regression, a family history of type 2 DM in 
first-degree relatives, elevated glucose levels at 60 min and at 120 min, elevated HbA1c, 
and perinatal complications were significantly different for women developing 
postpartum GI. Next, multivariate logistic regression was performed to determine the 
predictive factors. Glu120 in women with GI was significantly higher than in those with 
NGT. The HbA1c level was significantly higher in women with GI than in those with 
NGT. The GI rate associated with perinatal complications was significantly higher than 
the NGT rate (Table 2). 
Table 2. Univariate analysis and multivariate analysis of postpartum glucose 
intolerance. 
 Univariate logistic regression Multivariate logistic regression 
 Odds 
Ratio 
P 
value 
95% 
confidence 
interval 
Odds 
Ratio 
P 
value 
95% 
confidence 
interval 
Glucose at 120 min 
per 1 mg/dl 
1.03 0.002 1.01–1.05 1.04 0.008 1.01–1.07 
HbA1c at 
diagnosis (%) 
13.23 0.002 2.50–69.99 5.39 0.016 1.04–40.20 
Perinatal 
complication 
4.48 0.006 1.52–13.17 7.38 0.009 1.59–44.37 
Family history of 
DM in first degree 
relatives 
2.99 0.02 1.14–7.91 3.71 0.07 0.5–7.3 
Glucose at 60 min 
per 1 mg/dl 
1.02 0.02 1.00–1.04      
 
3.3. Cutoff level and classification of postpartum glucose intolerance 
A ROC curve was plotted to identify the cutoff level for GI that had developed 
postpartum, using Glu120 and HbA1c levels at the time of diagnosis. The cutoff value 
of Glu120 was determined as 155 mg/dl (area under the curve [AUC] 0.78; sensitivity, 
88.6%; specificity, 57.5%), and the cutoff value of HbA1c was 5.3% (34 mmol/mol) 
(AUC 0.62, sensitivity, 61.5%; specificity, 91.2%). 
The incidence of DM, IGT, IFG, and NGT within 2 years after delivery was 
significantly higher in the group with HbA1c levels over 5.3% (34 mmol/mol) or 
Glu120 levels over 155 mg/dl. Similarly, the GI incidence was significantly higher in 
the group with perinatal complications (Table 3). 
Table 3. Levels of HbA1c at diagnosis or glucose at 120 min during pregnancy, by each 
cutoff level and perinatal outcome, and screening for postpartum glucose tolerance after 
2 years. 
 Diabetes IGT IFG NGT Total 
HbA1c (%)* 
HbA1c ≥ 5.3 33.3% (9) 40.7% (11) 11.1% (3) 14.8% (4) 100% (27) 
HbA1c < 5.3 8.3% (3) 0% (0) 13.9% (5) 77.8% (28) 100% (36) 
Glucose at 120 min (mg/dl)* 
Glu120 ≥ 155 31.3% (16) 25.5% (13) 0% (0) 43.1% (22) 100% (51) 
Glu120 < 155 3.8% (1) 7.7% (2) 23.1% (6) 65.4% (17) 100% (26) 
Perinatal complication* 
(−) 16.7% (9) 9.3% (5) 9.3% (5) 64.8% (35) 100% (54) 
(+) 30.4% (7) 47.8% (11) 8.7% (2) 13.0% (3) 100% (23) 
Values represent ratio and number of patients. IGT, impaired glucose tolerance; IFG, 
impaired fasting glucose; NGT, normal glucose tolerance. 
* 
P < 0.05. 
Fig. 1A shows the classification into four groups, using the determined cutoff values of 
HbA1c and Glu120. The group with Glu120 levels over 155 mg/dl and HbA1c levels 
over 5.3% (34 mmol/mol) had a significantly higher postpartum GI than other groups. 
The group with both lower HbA1c and Glu120 levels had no DM and 27.8% of them 
developed IFG. The positive predictive value of IFG onset was 27.8% (sensitivity, 
71.4%; specificity, 74.0%) in the low HbA1c and low Glu120 group compared with the 
other groups. In contrast, the positive predictive value of IGT onset was 4.5% 
(sensitivity, 4.5%; specificity, 51.4%) in this group compared with the other groups. 
Furthermore, Fig. 1B shows the proportion of Glu120 and HbA1c in each glucose 
metabolism status. 
  
Fig. 1. Four groups were classified according to the levels of HbA1c at diagnosis or 
glucose levels at 120 min during pregnancy (a)–(d) and screening for postpartum 
glucose tolerance after 2 years. 
 
3.4. Status of glucose metabolism at 2 years postpartum 
To determine postpartum GI following a GI status at the time of diagnosis, the 75-g 
OGTT data obtained 2 years after delivery were observed (Fig. 2). HbA1c levels at the 
time of diagnosis were used to create two groups: one with an HbA1c level of 5.3% 
(34 mmol/mol) or higher and another with HbA1c level lower than 5.3% 
(34 mmol/mol). Blood glucose values and insulin values, determined using 75-g 
OGTTs, were observed 2 years later. In the high HbA1c group, the blood glucose level 
and the insulin value after two hours were significantly higher. There was no difference 
in the insulinogenic index in the high HbA1c group, but the Matsuda index was 
significantly lower. 
  
Fig. 2. Postpartum glucose tolerance in two groups classified according to the levels of 
HbA1c at diagnosis or glucose levels at 120 min. 
Similarly, at the time of diagnosis, two groups were formed, divided according to 
whether they had a Glu120 level of 155 mg/dl or higher after the OGTT, and were 
examined 2 years later. In the high Glu120 group, blood glucose levels after 60, 90, and 
120 min were significantly higher. In the high Glu120 group, the insulinogenic index 
was significantly lower (0.62 ± 0.48 vs. 0.94 ± 0.51, P < 0.05), but the Matsuda index 
did not differ (5.87 ± 2.87 vs. 6.10 ± 3.88). 
 
4. Discussion 
 
In our study, using 75-g OGTTs, we showed that elevated Glu120, elevated HbA1c 
levels during GDM diagnosis, and perinatal complications can predict postpartum 
glucose tolerance. More than 90% of women with both high Glu120 and high HbA1c 
levels at diagnosis developed DM or IGT within 2 years. High Glu120 and high HbA1c 
levels were associated with reduced insulin secretion and insulin resistance, 
respectively, at 2 years after delivery. 
Other reports have also indicated some risk factors for postpartum glucose tolerance 
[22], [23], [24], [25], [26], [27], [28]. Most of the predictive factors for diabetes that are 
reported in current publications refer to GDM diagnosed using criteria developed before 
the GDM diagnostic criteria were updated by the IADPSG [29]. To determine a GDM 
diagnosis consistent with the IADPSG requirements, a 75-g OGTT was performed in 
Iran between 6 and 12 weeks after delivery [30]. In the present study, a 75-g OGTT was 
continuously inspected for 2 years under the new diagnostic criteria, and no studies 
reporting further GI risk factors have been found. 
Furthermore, HbA1c levels at the time of diagnosis were associated with insulin 
sensitivity at 2 years after delivery. The 2-h blood glucose level in OGTT at diagnosis 
was related to insulin secretion. These two novel findings have not been previously 
reported. It is noteworthy that the state of glucose metabolism during pregnancy reflects 
the state of glucose metabolism 2 years later. 
We hypothesized that the incidence of DM and associated risk factors may vary 
depending on ethnicity. Many studies have evaluated risk factors in mixed ethnic 
populations. Ethnic differences may reflect an underlying variation in maternal insulin 
sensitivity and secretion. In a study focused on ethnic differences, three months 
postpartum, 31% of women of non-European ethnicity and 18% of women of European 
ethnicity were glucose tolerant [31]. 
East Asians have a relatively low BMI and a weak insulin secretion capacity that cannot 
be compensated for by an increase in insulin resistance, due to the prevalence of limited 
obesity. The underlying pathophysiology of DM in this population is thought to differ 
from that in other ethnicities [32]. Additionally, East Asian patients with type 2 DM 
show a higher risk of developing DM-related complications than Europeans [33]. In the 
present study, only high-risk East Asians were included and all were of Japanese 
ethnicity, apart from one of Chinese ethnicity. 
Some studies have reported that a high fasting glucose level at diagnosis of OGTT 
during pregnancy was a risk factor for DM [23], [24], [25], [28], [29]. However, a 
fasting blood glucose level was not determined in the present study. Therefore, in this 
study, overt DM in pregnancy was not considered. Most of the previous reports on 
Asian populations included overt DM in pregnancy diagnosed according to GDM 
criteria in use prior to the application of the new IADPSG diagnostic criteria. Only one 
study from Iran reported that fasting blood glucose level with postpartum DM or IGT 
was a risk factor in accordance with IADPSG diagnostic criteria [30]. That study 
differed from our study because OGTT was performed shortly after delivery (6–
12 weeks) and in West Asians, the mean fasting blood glucose level of the DM or IGT 
groups was 5.9 mmol/l [107 mg/dl]. In addition, our study of an East Asian population 
involved a 2-year follow-up after delivery, and the average fasting blood glucose values 
of the DM or IGT groups were as low as 5.0 mmol/l [91 mg/dl]. Other studies have 
reported that the postpartum DM risk was due mainly to elevated postprandial glucose, 
in line with our results [9], [26], [27]. 
Many Asian GDM patients are not diagnosed with obesity, therefore BMI is unlikely to 
be a risk factor for DM development [34]. It has also been reported that postpartum 
BMI reduction suppresses DM onset even in individuals with relatively high BMI [35]. 
Furthermore, in a study reporting pre-pregnancy BMI, GDM was determined according 
to the old diagnostic criteria; therefore, it is possible that the population involved was 
different from the population in our study. Pre-pregnancy BMI has been regarded as a 
risk factor for the onset of diabetes in Asian populations [36], [37]. However, in these 
studies, analyses including GDM and overt DM in pregnancy were based on database 
information. These populations did not include GDM that involved lower blood glucose 
because the population was classified based on previous diagnostic criteria. Therefore, 
there was a possibility that these populations differed from the population in our 
analysis. However, it has been reported that a change in postpartum BMI was more 
useful as a predictive risk factor for diabetes onset than pre-pregnancy BMI [35]. 
In the present study, it is possible that pre-pregnancy BMI was not determined as a risk 
factor as this was a study conducted on East Asian women; hence, many non-obese 
women with GDM were included. 
Furthermore, some studies have also included women with positive autoimmune 
antibodies who are at high risk of developing type 1 DM [38]. 
We distinguished between four groups, using specific cutoff levels of Glu120 and 
HbA1c. The majority of women with higher Glu120 and HbA1c levels developed DM 
or IGT. In contrast, a minority of women with lower Glu120 and HbA1c levels 
developed DM or IGT. However, many IFG patients had lower glucose and HbA1c 
levels. The reason for this result is unclear but these two groups are likely to have 
different characteristics. 
As the total follow-up rate was low [11], [39], women with a previous history of GDM 
need to be classified according to a risk scale. Patients with both high Glu120 and high 
HbA1c levels, and with previous GDM, should undergo a 75-g OGTT annually for at 
least 2 years. 
In contrast, patients with low Glu120 and low HbA1c levels with previous GDM, did 
not develop DM within the 2-year period. In addition, these patients developed IFG and 
IGT (Fig. 1A). The positive predictive level and the sensitivity of IFG onset are higher 
in the low Glu120 and low HbA1c group than in the other groups. It is possible that the 
blood glucose level after glucose loading in these patients increased only slightly within 
2 years following delivery. Therefore, we consider that, in these patients, a simpler, 
more economical and efficient follow-up examination over 2 years following delivery is 
sufficient to determine fasting blood glucose and HbA1c levels. The number of women 
who continue with postpartum follow-up examinations may increase using these simple 
tests, rather than undertaking an annual OGTT. 
To better understand the mechanisms involved in determining each risk factor, we also 
correlated postpartum glucose and insulin results from the 75-g OGTTs with the HbA1c 
or Glu120 levels. 
The group with higher HbA1c levels showed higher insulin resistance after 2 years, and 
the group with higher Glu120 levels showed hyperglycemia after a glucose load, and a 
reduced insulinogenic index regarding insulin secretion in the early phase. However, not 
all data regarding 75-g OGTTs for the 77 patients were assessed, because some of the 
relevant OGTT data from patients who developed DM within 2 years were missing. 
Therefore, there is insufficient information available to explore these hypotheses further. 
As mentioned, East Asians with lower insulin secretion tend to develop DM with a 
slight increase in insulin resistance. Among them, insulin secretion in the early phase of 
the 2-year period following delivery in the high Glu120 group was lower than that of 
the low Glu120 group, which was considered a high-risk group for future onset DM. 
Moreover, insulin resistance after 2 years was more likely to develop in the group with 
high HbA1c levels at diagnosis, than in those with a low HbA1c level. Although the 
relationship between insulin resistance and HbA1c at diagnosis is unknown, 
improvement of insulin resistance through a healthier lifestyle may help prevent DM 
onset in the high HbA1c group. 
The odds ratio for Glu120 was 1.04; for HbA1c, 5.39; and for perinatal complications, 
7.38. Therefore, perinatal complications are the most relevant to the onset of glucose 
tolerance after delivery, followed by HbA1c, and then by Glu120. Among these risk 
factors, Glu120 and HbA1c at diagnosis were evident during pregnancy. To prevent 
interruption of postpartum follow-up examinations, education of patients with GDM 
during pregnancy was important. We hypothesized that the follow-up examination rate 
would increase if patients were aware of the disease risk during pregnancy. Therefore, 
we aimed to classify the risk through assessing Glu120 and HbA1c levels at diagnosis, 
which could then be used for education during pregnancy. 
Some patients presented with newly developed IGT after 2 years, while IGT was 
observed 3 months after delivery in others. Even if IGT improved to NGT within the 2-
year study period, there were cases in which glucose metabolism worsened over the 
following 2-year period. In addition, DM cases were also observed in the year following 
IGT. When these patients were evaluated for insulin secretion and sensitivity 
(insulinogenic index, Matsuda Index), IGT that had not improved for a considerable 
time was often diagnosed. These patients would be expected to further progress to an 
irreversible diabetic state. Therefore, we considered these patients as having impaired 
glucose tolerance, which is different from normal glucose status, and they were 
followed up for 2 years. 
There are several limitations to the present study, as follows: (1) data were extracted 
from only one facility in an Advanced Maternal and Child Medical Center; (2) this was 
a retrospective study based on medical records; (3) at diagnosis, the insulin level was 
barely detected; hence, insulin secretion and insulin sensitivity were not estimated 
during pregnancy, and insulin measurement was performed by chance during 
pregnancy; (4) the study comprised a small number of patients; (5) the study duration 
comprised only 2 years of observation; (6) high rate of lost to follow-up OGTT, and; (7) 
postpartum DM and GI were collectively analyzed as an outcome. While the GI may 
normalize, DM does not normalize, and they both present differently with respect to 
glucose metabolism. However, in this study, GI and DM were both considered as an 
abnormality of glucose metabolism. Selection bias could have occurred in terms of 
perinatal complication cases because many patients with high perinatal complication 
risks are admitted at our hospital as it is a highly specialized medical center. It would be 
preferable, therefore, to collect prospective data and insulin levels at diagnosis from 
numerous facilities. 
Furthermore, loss of body weight for 2 years, and breastfeeding after delivery, were 
previously reported as factors for preventing DM onset [40]. However, we could not 
retrieve these data because they were not included in our medical records. We need to 
plan prospective studies that include these factors accordingly. 
In conclusion, elevated Glu120, elevated HbA1c levels, and perinatal complications are 
predictive factors of DM and IGT onset for women with a history of GDM within 
2 years of delivery. 
 
Fig. A1. ROC analysis. 
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